vita-merfen 1 mg/g + 5 mg/g + 2000 iu/g ointment
novartis consumer health gmbh - Хлорхексидин, ретинол, хлорид benzoxonium - 1 mg/g + 5 mg/g + 2000 iu/g ointment
almagel a 436 mg/150 mg/218 mg/10 ml oral suspension
Актавис ЕАД - Бензокаин, алуминиев оксид, магнезиев оксид - 436 mg/150 mg/218 mg/10 ml oral suspension
suvaxyn circo+mh rtu
zoetis belgium sa - inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2 orf2 protein, inactivated mycoplasma hyopneumoniae, strain p-5722-3 - Инактивированные вирусни и инактивированные бактериални ваксини - Прасета - За активна имунизация на свинете с 3-седмична възраст срещу свинският цирковирус тип 2 (pcv2) за намаляване на вирусния товар в кръвта и от лимфоидни тъкани и фекални избледняват, причинени от инфекция с ЦВС2. За активна имунизация на прасета на възраст над 3 седмици срещу mycoplasma hyopneumoniae за намаляване на белодробни лезии, причинени от инфекция с М. hyopneumoniae.
endoject 2, 5 g/10 g паста
Рихтер Фарма ЕООД - formosulfathiazole - паста - 2, 5 g/10 g - крави
mhyosphere pcv id
laboratorios hipra, s.a. - mycoplasma hyopneumoniae, strain 7304 (nexhyon), expressing the capsid protein of porcine circovirus type 2a, inactivated - immunologicals for suidae, inactivated viral and inactivated bacterial vaccines - Прасета - for the active immunisation of pigs:to reduce lung lesions associated with porcine enzootic pneumonia caused by mycoplasma hyopneumoniae. also, to reduce the incidence of these lesions (as observed in field studies). to reduce viraemia, virus load in lungs and lymphoid tissues and the duration of the viraemic period associated with diseases caused by porcine circovirus type 2 (pcv2). efficacy against pcv2 genotypes a, b and d has been demonstrated in field studies. to reduce culling rate and the loss of daily weight gain caused by mycoplasma hyopneumoniae and/or pcv2 related diseases (as observed at 6 months of age in field studies). mycoplasma hyopneumoniae: onset of immunity: 3 weeks after vaccinationduration of immunity: 23 weeks after vaccinationporcine circovirus type 2:onset of immunity: 2 weeks after vaccinationduration of immunity: 22 weeks after vaccinationin addition, a reduction in nasal and faecal shedding and the duration of nasal excretion of pcv2 was demonstrated in animals challenged at 4 weeks and at 22 weeks after vaccination.